Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Aristotle University Of Thessaloniki
Age
21–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient has exfoliation syndrome with ocular hypertension, or exfoliative glaucoma and is older than 29 years
Patient is newly diagnosed, or currently untreated and exhibits untreated morning IOP (2 separate IOP readings at 10:00)greater than 29 mm Hg in the study eye
Study patients should have mild to moderate exfoliative glaucoma (VF loss \<12 dB; cupping 0.8 or less)
Patient with exfoliation syndrome should fulfill the IOP criterion (IOP \> 29 mm Hg at 10:00)
Patient deemed by investigator to require significant IOP reduction to obtain desired target IOP
Patient agrees to be treated for at least 3 months with latanoprost and bimatoprost/timolol fixed combination drops dosed in the evening
In study eye distance best corrected Snelen visual acuity greater than 1/10
You may not be if
Contraindications to therapy with latanoprost, bimatoprost, or β-blockers
History of non-adherence or previously recorded evidence of lack of response (\<10% morning IOP reduction) to any antiglaucoma medication
Patient can not understand the instructions and adhere to medications
Patient is a female of childbearing potential or lactating mother
Past history of trauma, inflammation, surgery, past use of steroids (within 2 months), severe dry eyes and use of contact lenses
Signs of ocular infection, except blepharitis, or corneal abnormality that may affect IOP measurements
The other eye can not receive the same therapy, or remain without medical therapy
